Comments to FDA: Proposal to Revise CP Regulation Share page: CHPA submits these comments on the proposal published by the Food and Drug Administration in 64 Fed. Reg. 66822 (November 30, 1999) to revise its citizen petition regulations, 21 C.F.R. § 10.25 and 21 C.F.R. § 10.30. Download Document Issues: OTC Medicines Related Posts Press Releases and Statements CHPA Submits Official Comments on Section 232 National Security Investigation of Pharmaceuticals May 8, 2025 Press Releases and Statements CHPA Responds to HHS/FDA Announcement to Phase Out Petroleum-based Synthetic Dyes from America’s Food Supply Apr 22, 2025 Press Releases and Statements Health In Hand Foundation Announces Call for Nominations: 2025 U.S. Self-Care Marketing Awards Apr 22, 2025